Heike Daldrup-Link

Heike Daldrup-Link

Pediatric radiologist

Bio:   Heike Elisabeth Daldrup-Link is a clinician-scientist in the Department of Radiology at Stanford University with subspecialisation in pediatric radiology, pediatric oncology imaging, and molecular imaging. Dr. Daldrup-Link trained at the University of Münster and the Technical University of Munich, Germany. She worked as an Assistant and Associate Professor at the University of California, San Francisco from 2003 to 2010, before joining Stanford Radiology in 2010. Her research interest focuses on the development of novel pediatric molecular imaging techniques, which interface observations of living cells with nanoparticle development and multimodality imaging technologies:
Dr. Daldrup-Link developed several novel concepts for pediatric oncology imaging, such as tumor characterization through the EPR effect (US6009342-A), MR imaging of tumor associated inflammation with iron oxide nanoparticles (Clin Ca Res 2011), image-guided cancer therapy without side effects through tumor-enzyme activatable theranostic nanoparticles (Small 2014) and radiation-free whole body staging of children with cancer (Lancet Oncology 2014). Dr. Daldrup-Link’s cellular imaging studies also yielded several new and patented ideas for in vivo imaging of stem cell transplants establishing immediately clinically applicable technologies for: in vivo stem cell tracking with FDA-approved nanoparticles (US14/161,315), in vivo imaging of stem cell rejection processes with immune-cell targeted tracers, and MRI-detection of stem cell apoptosis with enzyme-activatable contrast agents (ACS Nano 2015). Over the past 10 years, Dr. Daldrup-Link's team has received 77 honors and awards for innovative cellular imaging research.

Imaging Clinic (Radiology)

Professional Education

  • Board Certification: Radiology, American Board of Radiology (2015)
  • Fellowship: Schwabing Children's Hospital Kinderklinkik Schwabing (2003) Germany
  • Radiology Board Certification, Bavarian Medical Association (Bayerische Landesärztekammer; BLÄK), Radiology (2001)
  • Residency: Technical University of Munich (2001) Germany
  • Residency: University of Munster Medical School (2000) Germany
  • Fellowship: UCSF Department/Division of Radiology (1997) CA
  • Internship: University of Munster Medical School (1995) Germany
  • Medical Education: University of Munster Medical School (1993) Germany

Honors & Awards

  • 'Ken Fellows Lecture', The Children’s Hospital of Philadelphia (CHOP), PA (2016)
  • Author of the 10th and 17th most cited articles (out of 1,100 articles), Journal of Visualized Experiments (2011)
  • Berdon Award for the best basic science paper, published in Pediatric Radiology in 2008, Society for Pediatric Radiology (2009)
  • Berdon Award for the best basic science paper, published in Pediatric Radiology in 2011, Society for Pediatric Radiology (2012)
  • Caffey Award for Basic Sciences, Society for Pediatric Radiology (1997)
  • Caffey Award for Basic Sciences, Society for Pediatric Radiology (2007)
  • Coolidge Award for Research on Macromolecular MR Contrast Agents, Roentgen Society, Award sponsored by GE Medical Systems (2000)
  • Distinguished Investigator Award, Academy of Radiology Research (2012)
  • Distinguished Reviewer, Journal of Magnetic Resonance Imaging, International Society for Magnetic Resonance in Medicine (2011)
  • Editor's recognition award with special distinction for reviews for the journal Radiology, Radiology Editorial Board (2010)
  • Editor's recognition award with special distinction for reviews for the journal Radiology, Radiology Editorial Board (2011)
  • Harvey White Memorial Lecture, Ann & Robert H. Lurie Children’s Hospital, Northwestern University Feinberg School of Medicine, Chicago (2013)
  • Innovation in Science Award for Research on Targeted MR Contrast Agents, University of California in San Francisco (UCSF) (2005)
  • Jorge Barrio Plenary Lecture for Advances in Clinical Research on Stem Cell Imaging, World Molecular Imaging Congress (2014)
  • Member, American Society for Clinical Investigation (ASCI) (2015)
  • New Investigators Award, American Association of University Radiologists (AUR) (2006)
  • R.O.S.E. Award (Recognition of Service Excellence), Lucile Packard Children's Hospital, Stanford University (2012)
  • Research featured on the cover of the March issue, Small (2014)
  • Research featured on the cover of the September issue, Clinical Cancer Research (2011)
  • Roentgen Award for research on "New Molecular Imaging Techniques for Bone Marrow Imaging", Roentgen Society (2005)
  • RSNA Bronze Visionary Donor Award (T. Link and H. Daldrup-Link), RSNA Research & Education Foundation (2017)
  • Stipend for International Young Academics, Radiological Society of North America (RSNA) (2002)

Administrative Appointments

  • Associate Chair of Diversity, Department of Radiology, Stanford School of Medicine (2017 - Present)
  • Associate Editor/Contrast Media, Radiology (2011 - Present)
  • Category Chair, “Cellular Imaging", World Molecular Imaging Congress (2012 - 2016)
  • Chair, Communications and Publications Committee, World Molecular Imaging Society (WMIS) (2015 - Present)
  • Chair, Imaging and Radiotherapeutics Committee, American Association for Cancer Research Annual Meeting (2010 - 2010)
  • Co-Chair (with S. Voss, Boston Childrens Hospital), ACR Committee on Pediatric Imaging Research, American College of Radiology (2013 - 2017)
  • Co-Director, Cancer Imaging & Early Detection Program, Stanford Cancer Institute (2017 - Present)
  • Director, Pediatric Molecular Imaging, Molecular Imaging Program at Stanford (2017 - Present)
  • NIH Study Section Member, Cancer Immunopathology and Immunotherapy Study Section (CII) (2010 - 2016)

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.